CMS proposes increasing payments to Medicare Advantage plans by an average of 1.35% in 2017 in contrast to proposed cuts in recent years.
CMS is proposing to increase payments for Medicare Advantage plans by an average of 1.35% for 2017. The agency is also proposing to improve the precision of payments to plans that service vulnerable populations, to adjust the Star Ratings to reflect socioeconomic and disability status of a plan’s enrollees, and to revise methodology used to risk adjust payments.
The modest payment increase is a contrast to the proposed cuts from CMS in recent years.
“These proposals continue to keep Medicare Advantage strong and stable and as with this past year, support the provision of high quality, affordable care to seniors and people living with disabilities," CMS Acting Administrator Andy Slavitt said in a statement. “In particular, these proposals support investment in dually Medicare-Medicaid eligible individuals and those with complex socioeconomic needs.”
Since the implementation of the Affordable Care Act, Medicare Advantage enrollment has increased 50% to cover 17.1 million beneficiaries. Nearly one-third of all Medicare beneficiaries are enrolled in a Medicare Advantage plan.
According to CMS, the average number of Medicare plan choices remained consistent in 2016 compared with 2015.
“While we are in the process of carefully reviewing all of these provisions, we will be looking closely at any proposals that would undermine health plans' care coordination and disease management programs, especially for low-income individuals,” Marilyn Tavenner, president and CEO of America’s Health Insurance Plans, said in a statement. “It's critically important that the agency finalize policies that ensure the long-term stability and continued growth of the program for millions of beneficiaries who depend on Medicare Advantage for their coverage."
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More